Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal Antibodies against IL-12 p40 Monomer

Although some therapies are available for regular breast cancers, there are very few options for triple-negative breast cancer (TNBC). Here, we demonstrated that serum level of IL-12p40 monomer (p40) was much higher in breast cancer patients than healthy controls. On the other hand, levels of IL-12,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kundu, Madhuchhanda, Raha, Sumita, Roy, Avik, Pahan, Kalipada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773899/
https://www.ncbi.nlm.nih.gov/pubmed/35053375
http://dx.doi.org/10.3390/cells11020259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773899/
https://www.ncbi.nlm.nih.gov/pubmed/35053375
http://dx.doi.org/10.3390/cells11020259

Ejemplares similares